Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients.

MLA

Ruiz, M. I.Galleges, et al. “Combined Assessment of EGFR Pathway-Related Molecular Markers and Prognosis of NSCLC Patients.” British Journal of Cancer, vol. 100, no. 1, Jan. 2009, pp. 145–52. EBSCOhost, https://doi.org/10.1038/sj.bjc.6604781.

APA

Ruiz, M. I. G., Floor, K., Steinberg, S. M., Grünberg, K., Thunnissen, F. B. J. M., Belien, J. A. M., Meijer, G. A., Peters, G. J., Smit, E. F., Rodriguez, J. A., Giaccone, G., Galleges Ruiz, M. I., & Grünberg, K. (2009). Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients. British Journal of Cancer, 100(1), 145–152. https://doi.org/10.1038/sj.bjc.6604781

Chicago

Ruiz, M. I. Galleges, K. Floor, S. M. Steinberg, K. Grünberg, F. B. J. M. Thunnissen, J. A. M. Belien, G. A. Meijer, et al. 2009. “Combined Assessment of EGFR Pathway-Related Molecular Markers and Prognosis of NSCLC Patients.” British Journal of Cancer 100 (1): 145–52. doi:10.1038/sj.bjc.6604781.